Cresco Labs (CRLBF) Other Operating Expenses (2020 - 2025)
Cresco Labs' (CRLBF) quarterly Other Operating Expenses came in at $101.9 million in Q4 2025, up 3212.84% YoY from $3.1 million in Q4 2024, and up 7175.14% on a QoQ basis from $1.4 million in Q3 2025.
Cresco Labs (CRLBF) Other Operating Expenses (2020 - 2025) Analysis & Trends
Cresco Labs (CRLBF) has 6 years of Other Operating Expenses data on file, last reported at $101.9 million in Q4 2025.
- Quarterly Other Operating Expenses rose 3212.84% year-over-year to $101.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $102.4 million (up 263.95% YoY) and the FY2025 annual result came in at $105.1 million, up 269.71% from the prior year.
- Other Operating Expenses rose to $101.9 million in Q4 2025, from $1.4 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $295.8 million in Q3 2021 to a low of -$59.5 million in Q2 2024.
- A 5-year average of $30.0 million and a median of $323000.0 in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2021 — Other Operating Expenses jumped 83656.38% — and 2024, when it slumped 14902.99%.
- Tracing CRLBF's Other Operating Expenses over 5 years: stood at $10.9 million in 2021, then surged by 1283.83% to $151.0 million in 2022, then sank by 99.97% to $50000.0 in 2023, then slumped by 6644.0% to -$3.3 million in 2024, then surged by 3212.84% to $101.9 million in 2025.
- The last three Other Operating Expenses figures came in at $101.9 million (Q4 2025), $1.4 million (Q3 2025), and -$836000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Cresco Labs | 291.27 Mn | 227.16 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.85 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | -836,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Dec 31, 2024 | -3.27 Mn |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -59.51 Mn |
| Mar 31, 2024 | 856,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 329,000.00 |
| Jun 30, 2023 | 402,000.00 |
| Dec 31, 2022 | 150.99 Mn |
| Mar 31, 2022 | -6.77 Mn |
| Dec 31, 2021 | 10.91 Mn |
| Sep 30, 2021 | 295.79 Mn |
| Mar 31, 2021 | -12.34 Mn |
| Dec 31, 2020 | -18.47 Mn |
| Sep 30, 2020 | -354,000.00 |
| Jun 30, 2020 | 73,000.00 |
| Mar 31, 2020 | 10.46 Mn |